Finance
Guggenheim raises Oruka Therapeutics stock price target to $200 on trial data
Guggenheim raises Oruka Therapeutics stock price target to $200 on trial data
I
Investing.com
April 27, 2026·1 min read
GM
FinanceGuggenheim raises Oruka Therapeutics stock price target to $200 on trial data
Original article
Guggenheim raises Oruka Therapeutics stock price target to $200 on trial data
Published by Investing.com